Dr. Kenneth Floyd Rice, D.M.D. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 986 S Main St, Snowflake, AZ 85937 Phone: 928-536-7159 Fax: 928-536-7150 |
Dr. German Antonio Sierra, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 155 W Center St, Snowflake, AZ 85937 Phone: 928-536-7158 Fax: 928-536-2640 |
Dr. Craig Reed West, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 439 S. Main Street, Snowflake, AZ 85937 Phone: 928-536-4182 Fax: 928-536-4182 |
Dr. Travis Lynn Caskey, D.M.D. Dentist Medicare: Medicare Enrolled Practice Location: 986 S Main St, Snowflake, AZ 85937 Phone: 928-536-7159 |
Dr. Bryce Jones, DMD Dentist Medicare: Medicare Enrolled Practice Location: 932 S Main St, Snowflake, AZ 85937 Phone: 928-536-5773 |
James Randall Olson, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 986 S Main St, Snowflake, AZ 85937 Phone: 928-536-5353 Fax: 928-536-5353 |
Taylor Hunt, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 155 W Center St, Snowflake, AZ 85937 Phone: 928-536-7158 |
Dr. Brian D. Birtcher, D.D.S. Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 932 S Main St, Suite C, Snowflake, AZ 85937 Phone: 928-536-5773 Fax: 928-536-7115 |
News Archive
Bone marrow transplant offers patients with leukemia and lymphoma a potentially curative treatment. Bone marrow from the donor contains healthy immune cells, whose mission is to protect the body from invaders.
Neurons die en masse when the spinal cord is injured or when a person suffers a stroke. Researchers of the Max Delbrueck Center for Molecular Medicine (MDC) Berlin-Buch, Germany, and of Aarhus University, Denmark, have unraveled the molecular mechanism which causes the death not only of damaged neurons, but also of healthy nerve cells.
With an overall survival rate of 9% for those diagnosed, pancreatic cancer remains exceedingly difficult to treat. However, the patient's primary tumor typically isn't what leads to death - it is the cancer's ability to evade detection and metastasize to other organs.
Bristol-Myers Squibb and Pfizer Inc. today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion recommending that ELIQUIS (apixaban) be granted approval for the prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) and one or more risk factors for stroke.
When combined with a detailed medical history, it can identify the causes of allergy symptoms and provide the basis for avoidance, environmental control and immunotherapy.
› Verified 9 days ago